1-3 of 3
Moira Micheletti, MD
Close
Sort by
Journal Articles

A 3-Year Prospective Surveillance Study of Microbiological Isolates among Hematologic Inpatients Shows a High Frequency of Both Community-Acquired and Nosocomial Methicillin-Resistant (MR) and Fluoroquinolone-Resistant (FqR) Strains and the Recent Increase of Enterococci, Viridans Streptococci and Pseudomonaceae with Frequent Antibiotic Multiresistance.

Chiara Cattaneo, MD, Salvatore Casari, MD, Erika Borlenghi, MD, Maria Adele Capucci, MD, Moira Micheletti, MD, Alessandro Re, MD, Giampiero Carosi, MD, Giuseppe Rossi, MD
Journal: Blood
Blood (2007) 110 (11): 2286.
https://doi.org/10.1182/blood.V110.11.2286.2286
Published: 2007
Journal Articles

An Analysis of the Incidence, Risk Factors and Prognosis of Acute Promyelocytic Leukemia Following Mitoxantrone Therapy in Patients Affected by Multiple Sclerosis.

Chiara Cattaneo, MD, Erika Borlenghi, MD, Cinzia Cordioli, MD, Samantha Ferrari, MD, Antonio Regazzoli, MD, Giuseppina Ruggeri, MD, Elena Gobbi, Maria Adele Capucci, MD, Moira Micheletti, MD, Ruggero Capra, MD, Giuseppe Rossi, MD
Journal: Blood
Blood (2006) 108 (11): 4488.
https://doi.org/10.1182/blood.V108.11.4488.4488
Published: 2006
Journal Articles

The Combined Use of Hydroxyurea and Anagrelide Allows Better Hematologic Control in Patients with Chronic Myeloproliferative Disorders and Thrombocytosis. A Report on 13 Patients with Poor Tolerance to Hydroxyurea Monotherapy.

Moira Micheletti, MD, Mariella D’Adda, MD, Monica Drera, MD, Samantha Ferrari, MSt, Giuseppe Rossi, MD
Journal: Blood
Blood (2006) 108 (11): 4892.
https://doi.org/10.1182/blood.V108.11.4892.4892
Published: 2006